Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma

BJU International

Volumn 108, Issue 5, 2011, Pages 673-678

  Staehler, Michael ^a   Haseke, Nicolas ^a   Nuhn, Philipp ^a   Tüllmann, Cordula ^a   Karl, Alexander ^a   Siebels, Michael ^a   Stief, Christian G ^a   Wowra, Berndt ^b   Muacevic, Alexander ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b European CyberKnife Center Munich   (Germany)

Author keywords

cerebral metastasis; cyberknife; renal cell cancer; robotic surgery; sorafenib; spinal tumours; stereotactic; sunitinib

Indexed keywords

SORAFENIB; SUNITINIB;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ANTIANGIOGENIC THERAPY; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN METASTASIS; CANCER CONTROL; CASE STUDY; CONTROLLED STUDY; CONVULSION; DEATH; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; HAND FOOT SYNDROME; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NEUROTOXICITY; OVERALL SURVIVAL; PRIORITY JOURNAL; SKIN TOXICITY; SPINAL CORD DISEASE; SPINAL CORD METASTASIS; STEREOTACTIC RADIOSURGERY; SYSTEMIC THERAPY; THERAPY EFFECT; THROMBOCYTOPENIA; THROMBOSIS; TUMOR BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PYRROLES; RADIOSURGERY; SPINAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953064777     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09895.x     Document Type: Article

References (29)

1. Ries LAG, Melbert D, Krapcho M, et al,. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute, 2008. Available at:, based on November 2007 SEER data submission, posted to the SEER web site. Accessed March 2010
2. Escudier B, Eisen T, Stadler WM, et al,. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356: 125-34 (Pubitemid 46089673)
3. Motzer RJ, Hutson TE, Tomczak P, et al,. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356: 115-24 (Pubitemid 46089672)
4. Hudes G, Carducci M, Tomczak P, et al,. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007; 356: 2271-81 (Pubitemid 46849157)
5. Escudier B, Pluzanska A, Koralewski P, et al,. Bevacizumab plus interferon α-2a for treatment of metastatic renal cell carcinoma: A randomised, double-blind phase III trial. Lancet 2007; 370: 2103-11 (Pubitemid 350296300)
6. Lee J, Hodgson D, Chow E, et al,. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer 2005; 104: 1894-900 (Pubitemid 41513172)
7. Ning S, Trisler K, Wessels BW, Knox SJ,. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer 1997; 80: 2519-28 (Pubitemid 28010140)
8. Wowra B, Siebels M, Muacevic A, Kreth FW, Mack A, Hofstetter A,. Repeated gamma knife surgery for multiple brain metastases from renal cell carcinoma. J Neurosurg 2002; 97: 785-93 (Pubitemid 35222398)
9. Siebels M, Oberneder R, Buchner A, et al,. [Ambulatory radiosurgery in cerebral metastatic renal cell carcinoma. 5-year outcome in 58 patients]. Urologe A 2002; 41: 482-8 (Pubitemid 36070154)
10. Hara W, Tran P, Li G, et al,. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma. Neurosurgery 2009; 64: A26-32
11. Tsai JT, Lin JW, Chiu WT, Chu WC,. Assessment of image-guided CyberKnife at radiosurgery for metastatic spine tumors. J Neurooncol 2009; 94: 119-27
12. Papatheofanis FJ, Williams E, Chang SD,. Cost-utility analysis of the cyberknife system for metastatic spinal tumors. Neurosurgery 2009; 64: A73-83
13. Gagnon GJ, Henderson FC, Gehan EA, et al,. Cyberknife radiosurgery for breast cancer spine metastases: a matched-pair analysis. Cancer 2007; 110: 1796-802 (Pubitemid 47557305)
14. Gerszten PC, Burton SA, Ozhasoglu C,. CyberKnife radiosurgery for spinal neoplasms. Prog Neurol Surg 2007; 20: 340-58
15. Ho AK, Fu D, Cotrutz C, et al,. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery 2007; 60: ONS147-56; discussion ONS156
16. Degen JW, Gagnon GJ, Voyadzis JM, et al,. CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. J Neurosurg Spine 2005; 2: 540-9
17. Gerszten PC, Welch WC,. Cyberknife radiosurgery for metastatic spine tumors. Neurosurg Clin N Am 2004; 15: 491-501 (Pubitemid 39278444)
18. Gerszten PC, Ozhasoglu C, Burton SA, et al,. CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases. Neurosurgery 2004; 55: 89-98; discussion 99 (Pubitemid 38859082)
19. Gerszten PC, Ozhasoglu C, Burton SA, et al,. Evaluation of CyberKnife frameless real-time image-guided stereotactic radiosurgery for spinal lesions. Stereotact Funct Neurosurg 2003; 81: 84-9 (Pubitemid 38209820)
20. Chang SD, Murphy M, Geis P, et al,. Clinical experience with image-guided robotic radiosurgery (the Cyberknife) in the treatment of brain and spinal cord tumors. Neurol Med Chir (Tokyo) 1998; 38: 780-3 (Pubitemid 28551346)
21. Muacevic A, Staehler M, Drexler C, Wowra B, Reiser M, Tonn JC,. Technical description, phantom accuracy, and clinical feasibility for fiducial-free frameless real-time image-guided spinal radiosurgery. J Neurosurg Spine 2006; 5: 303-12 (Pubitemid 47325368)
22. Chang SD, Main W, Martin DP, Gibbs IC, Heilbrun MP,. An analysis of the accuracy of the CyberKnife: a robotic frameless stereotactic radiosurgical system. Neurosurgery 2003; 52: 140-6; discussion 146-7
23. Wowra B, Zausinger S, Drexler C, et al,. CyberKnife radiosurgery for malignant spinal tumors: characterization of well-suited patients. Spine 2008; 33: 2929-34
24. Adler JR Jr, Chang SD, Murphy MJ, Doty J, Geis P, Hancock SL,. The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg 1997; 69: 124-8 (Pubitemid 28305430)
25. Staehler M, Haseke N, Schoppler G, Stadler T, Heinemann G, Stief CG,. [Managing the side effects of angiogenetic inhibitors in metastatic renal cell carcinoma]. Urologe A 2006; 45: 1333-42; quiz 43
26. Kasibhatla M, Steinberg P, Meyer J, Ernstoff MS, George DJ,. Radiation therapy and sorafenib: clinical data and rationale for the combination in metastatic renal cell carcinoma. Clin Genitourin Cancer 2007; 5: 291-4 (Pubitemid 46867367)
27. Diaz O, Mazeron R, Martin E, Carrie C,. [Toxicity of radiation therapy and antiangiogenics combination: a case report]. Cancer Radiother 2009; 13: 205-8
28. Motzer RJ, Bacik J, Schwartz LH, et al,. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 2004; 22: 454-63 (Pubitemid 41079774)
29. Ohlmann CH,. [Prognostic factors for survival of patients with metastatic renal cell carcinoma]. Urologe A 2009; 48: 625-7